DONALD O. CASTELL, M.D.
Medical therapy aimed at prevention of gastroesophageal reflux or treatment of the resulting esophagitis has been modified considerably during the past few years. A number of new drugs or new uses for old drugs have been shown in controlled treatment trials to be effective adjuncts in the therapy of this common problem (1-4). The prospect of new forms of therapy for a common problem often raises the possibility for older effective forms of therapy to be forgotten or mislaid. This may create the potential for overuse or abuse of the newer, less well-proven therapies.
In this issue, Thanik and colleagues
Learn more about subscription options.
Register Now for a free account.
CASTELL DO. Medical Therapy of Reflux Esophagitis. Ann Intern Med. 1980;93:926–927. doi: 10.7326/0003-4819-93-6-926
Download citation file:
Published: Ann Intern Med. 1980;93(6):926-927.
Esophageal Disorders, Gastroenterology/Hepatology, Gastroesophageal Reflux Disease, Peptic Disease, Peptic Ulcer.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only